Karen Soares, the Chief Legal Officer of Clover Health Investments, Corp., has sold 19,275 shares of the company’s Class A common stock. This transaction took place on October 20, 2026, and is part of a broader strategy for managing her financial interests.
The sale was executed at a weighted average price of $4.66 per share, with individual transaction prices ranging from $4.45 to $4.79. Following this sale, Soares retains ownership of 1,573,423 shares of Clover Health.
Background
Clover Health Investments, Corp. is a company focused on providing health insurance services. It operates under the Standard Industrial Classification of Hospital & Medical Service Plans. The company, which trades under the ticker symbol CLOV, is incorporated in Delaware and has its business address in Jersey City, New Jersey.
What the Filing Says
The SEC filing indicates that the shares were sold pursuant to a 10b5-1 plan that was adopted by Soares on March 13, 2026. This plan allows for pre-scheduled trades to avoid any potential conflicts of interest.
Impact
This transaction may impact Clover Health’s perception among investors and analysts, as executive stock sales can often be scrutinized for signals about a company’s performance. However, the planned nature of the sale through a 10b5-1 plan may alleviate some concerns regarding insider trading.
What's Next
The filing does not say what happens next.